Stock with Unusual Volume – Nomura Holdings, Gastar Exploration Limited, BioCryst Pharmaceuticals, NYSEARCA:JNK
New York, NY – (Net PR News) – 4/09/2013–smartOTC is the premiere destination for Investors and novices alike who wish to receive information on fast moving OTC stocks and undiscovered companies. Most of these companies are considered penny stocks and trade on the Pink Sheet or OTC BB market. Our daily alerts help investors cut their research time in half as we send out small cap and penny stock alerts that are displaying signs of a potential rally.
Sign up For Our No. 1 Rated Stock Newsletter to make Huge Profitshttp://www.smartotc.com
Nomura Holdings, Inc. (ADR) (NYSE:NMR) reported the gain of +6.98% and closed at $6.90 in the last trading session with the overall traded volume of 3.73 million shares. NMR has earnings per share of $0.13 and its price to earnings ratio is 54.14. Nomura Holdings, Inc. is engaged in the investment and financial services business with a focus on securities business. The Company’s business operations include financing, asset management, securities trading and brokerage, underwriting and sale of securities.
How Should Investors Trade NMR Now? Don’t Miss out on a Special Trend Analysis
Gastar Exploration Limited (USA) (NYSEAMEX:GST) shares went up +8.79% to close at $2.60 in the last trading session and its total traded volume was 2.52 million shares. Stock price 52 weeks high was $2.86 and 52 weeks low price was $0.70. Gastar Exploration Ltd (Gastar) is an independent energy company engaged in the exploration, development and production of natural gas and oil in the United States. The Company’s principal business activities include the identification, acquisition, and subsequent exploration and development of natural gas and oil properties with an emphasis on unconventional reserves.
What Are GST’s Charts Signaling for Traders? Find Out Here
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) soared +12.94% and closed at $1.92 in the last trading session with the overall traded volume of 14.60 million shares. BCRX has market cap of 97.87 million and its beta value stands at 2.43 times. BioCryst Pharmaceuticals, Inc. (BioCryst) is a biotechnology company. BioCryst designs, optimizes and develops drugs that block enzymes involved in the pathogenesis of diseases. The Company focuses on therapeutic areas.
Can BCRX Show a Strong Recovery? Find out in This Research Report
SPDR Barclays Capital High Yield Bnd ETF (NYSEARCA:JNK) gained +0.07% to close at $40.93 and its total volume in the last trading session was 14.23 million shares. JNK has market cap of 12.27 billion and its beta value stands at 0.74 times. SPDR Barclays High Yield Bond ETF (the Fund), formerly SPDR Barclays Capital High Yield Bond ETF, seeks to provide investment results that correspond to the price and yield performance of the Barclays Capital High Yield Very Liquid Index (the Index).
Should JNK be a Buy or Sell Now? Find Out Here
smartOTC is the premiere destination for Investors and novice alike who wish to receive information on fast moving OTC penny stocks and undiscovered companies. We are a marketing firm that releases paid reports on undiscovered companies looking to tell their stories. Most of these companies are considered penny stocks and trade on the Pink Sheet or OTC BB market. Our daily alerts help investors cut their research time in half as we send out small cap and penny stock alerts that are displaying signs of a potential rally.
While penny stocks pose a much more significant risk factor compared to large cap stocks, their lure of quick gains makes it a trading choice for many small time and beginner investors. There is nothing wrong with investments into penny stocks, the best advice is to do your own research and consult with your own financial professional. smartOTC reports and alerts should only be used as a starting point for your own due diligence.
PLEASE NOTE WELL: This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation.
Smartotc.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. The disclaimer is to be read and fully understood before using our site, or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities.
Read Our Full Disclaimer at http://www.smartotc.com/disclaimer